You are in the accessibility menu

Statistics

Total Visits

Views
The results of a randomized trial looking at 24 weeks vs 48 weeks of treatment with peginterferon alpha-2a (40 kDa) and ribavirin combination therapy in patients with chronic hepatitis C genotype 1 105

Total Visits per Month

September 2024 October 2024 November 2024 December 2024 January 2025 February 2025 March 2025
The results of a randomized trial looking at 24 weeks vs 48 weeks of treatment with peginterferon alpha-2a (40 kDa) and ribavirin combination therapy in patients with chronic hepatitis C genotype 1 1 0 1 1 8 8 1

File Downloads

Views

Top Country Views

Views
United States 55
Germany 23
China 8
Brazil 6
Russia 5
Ukraine 5
France 1
Japan 1
Vietnam 1

Top City Views

Views
Ashburn 17
San Mateo 8
Fairfield 7
Cambridge 6
Jacksonville 5
Seattle 3
Nanjing 2
Yang 2
Aptos 1
Brooklyn 1